AI & Data Analytics

How the start-up hopes its software platform will transform R&D.

It led to “missed opportunities” during the ACA rollout and a key time in the opioid epidemic.

The burgeoning gen-editing giant will test its zinc finger nuclease (ZFN) editing technology against lysosomal storage disorders in children.

The company plans to have a fully functional version commercialized in just a few months.

Can’t-miss insights on physician suicide, genealogy database ethics, and more.

"An objective, precise, compact, unambiguous, easily-interpretable description of all loops, stems, and pseudoknots."

Additional major US-based healthcare systems are also expected to participate in the RenalytixAI collaboration.

What you need to know from another busy week in health IT.

The concept might someday aid in the creation of more lifelike prosthetics (or robots).

Why investors like the company’s high-tech approach to patient outcomes.

“When I came across recent reports on deep-learning algorithms...I immediately knew that we had to explore these artificial intelligence algorithms for diagnosing melanoma.”

The insights you need to advance medicine’s digital transformation.

What you need to know to succeed in health IT and beyond.

Artificial intelligence is a field of boom and busts. In this episode of Data Book, we look at what it actually is and what it means for healthcare. Featuring guest Kevin Campbell, MD.

The FDA has permitted marketing of an artificial intelligence-based algorithm for detection of fractures in the wrist.

"We demonstrated that we can use [EHR] data in combination with other tools to accurately identify people at high risk."

How these technologies can solve common data problems.

Burden of disease is growing, and ophthalmology's people power may not be able to keep up. Healthcare must turn to machine learning to fill the gap.

How a data-driven “diagnostic cockpit” could help health systems.

NCI, the analytics and artificial intelligence solutions company, will dig into the data.

HIrisPlex-S could become a powerful force in healthcare, law enforcement, and beyond.

Patients who didn’t wean off opioids were more likely to obtain a prescription after discharge.

The country is committing billions into artificial intelligence research and plans to focus some of its efforts on earlier cancer detection.

From the $30B EMR market to physician burnout, these topics yielded great healthcare opinions and analyses.

CMS Administrator Seema Verma, MPH, is working to further expand access to health data.